Gabrielle Sulzberger, Director at Cerevel Therapeutics Holdings, Inc. (CERE), bought 42,168 shares at $13.06 ($551K) on 2021-06-17, disclosed to the SEC on 2021-06-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.06 | 21,084 | $275K | 50.0% |
| 2 | $13.06 | 21,084 | $275K | 50.0% |
| Total | $13.06 avg | 42,168 | $551K | 100% |
| Filing → |